Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 3
2005 1
2006 2
2007 6
2008 3
2009 2
2010 9
2011 4
2012 2
2013 6
2014 7
2015 3
2016 5
2017 4
2018 4
2019 5
2020 5
2021 9
2022 7
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow.
Allaeys I, Lemaire G, Leclercq M, Lacasse E, Fleury M, Dubuc I, Gudimard L, Puhm F, Tilburg J, Stone AP, Machlus KR, Droit A, Flamand L, Boilard E. Allaeys I, et al. Among authors: flamand l. Blood Adv. 2024 Mar 24:bloodadvances.2023012367. doi: 10.1182/bloodadvances.2023012367. Online ahead of print. Blood Adv. 2024. PMID: 38522092
SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice.
Willett JDS, Gravel A, Dubuc I, Gudimard L, Dos Santos Pereira Andrade AC, Lacasse É, Fortin P, Liu JL, Cervantes JA, Galvez JH, Djambazian HHV, Zwaig M, Roy AM, Lee S, Chen SH, Ragoussis J, Flamand L. Willett JDS, et al. Among authors: flamand l. Commun Biol. 2024 Feb 16;7(1):191. doi: 10.1038/s42003-024-05878-3. Commun Biol. 2024. PMID: 38365933 Free PMC article.
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series.
Colmegna I, Valerio V, Amiable N, Useche M, Rampakakis E, Flamand L, Rollet-Labelle E, Bessette L, Fitzcharles MA, Hazel E, McCormack D, Michou L, Panopalis P, Langlois MA, Bernatsky S, Fortin PR. Colmegna I, et al. Among authors: flamand l. RMD Open. 2023 Nov 29;9(4):e003400. doi: 10.1136/rmdopen-2023-003400. RMD Open. 2023. PMID: 38030231 Free PMC article. Clinical Trial.
SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κB.
Lacasse É, Gudimard L, Dubuc I, Gravel A, Allaeys I, Boilard É, Flamand L. Lacasse É, et al. Among authors: flamand l. Viruses. 2023 Jan 24;15(2):334. doi: 10.3390/v15020334. Viruses. 2023. PMID: 36851549 Free PMC article.
Impact of Host Telomere Length on HHV-6 Integration.
Wight DJ, Aimola G, Beythien G, Flamand L, Kaufer BB. Wight DJ, et al. Among authors: flamand l. Viruses. 2022 Aug 24;14(9):1864. doi: 10.3390/v14091864. Viruses. 2022. PMID: 36146670 Free PMC article.
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection.
Olivera-Ugarte SM, Bolduc M, Laliberté-Gagné MÈ, Blanchette LJ, Garneau C, Fillion M, Savard P, Dubuc I, Flamand L, Farnòs O, Xu X, Kamen A, Gilbert M, Rabezanahary H, Scarrone M, Couture C, Baz M, Leclerc D. Olivera-Ugarte SM, et al. Among authors: flamand l. Nanomedicine. 2022 Aug;44:102584. doi: 10.1016/j.nano.2022.102584. Epub 2022 Jul 16. Nanomedicine. 2022. PMID: 35850421 Free PMC article.
Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I, Prunier J, Lacasse É, Gravel A, Puhm F, Allaeys I, Archambault AS, Gudimard L, Villano R, Droit A, Flamand N, Boilard É, Flamand L. Dubuc I, et al. Among authors: flamand l. Front Immunol. 2022 Jun 24;13:893792. doi: 10.3389/fimmu.2022.893792. eCollection 2022. Front Immunol. 2022. PMID: 35812400 Free PMC article.
93 results